Skip to main content
Erschienen in: Acta Neurochirurgica 2/2015

01.02.2015 | Clinical Article - Brain Tumors

Anatomic features of glioblastoma and their potential impact on survival

verfasst von: U. Nestler, K. Lutz, U. Pichlmeier, W. Stummer, K. Franz, H-J Reulen, A. Bink, on behalf of the 5-ALA Glioma Study Group

Erschienen in: Acta Neurochirurgica | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Many reports on glioblastoma multiforme discuss the prognostic impact of anatomical features such as cysts, necrotic changes, extent of edema or subependymal spread of tumor cells. In the present study, we examined different growth patterns and their possible relations to patient survival.

Methods

To analyze whether anatomical characteristics are related to prognosis, we reviewed the prospectively collected pre- and postoperative MRIs of 83 patients in the 5-ALA study, provided by the 5-ALA Glioma Study Group. Following a standardized analytic work flow, the tumor volume and site, presence of necrosis or cysts, and perifocal edema were assessed preoperatively. In the same way, postoperative MRI and the MRI at first recurrence were analyzed. In addition, survival time of the patients was documented.

Results

Median survival time of all 83 patients was 15.1 months (range 1.5 to 70.1, mean 18). The site or volume of glioblastoma, as well as the presence of intratumoral necrosis or cysts, did not exert a significant effect on survival time; 96.4 % of recurrences occurred within the former resection margin. Tumors with initial contact with the subependymal zone had multifocal or ventricular recurrences significantly more often. In patients with residual tumor on early postoperative MRI, the follow-up images displayed enlargement of the remnants in 91.9 % of these cases.

Conclusions

A merely anatomical analysis of the glioblastoma growth pattern cannot reliably provide prognostic information. The occurrence of most recurrences next to the resection margin and the high percentage of growing residual tumors underline the importance of complete resections.
Literatur
1.
Zurück zum Zitat Adeberg S, Bostel T, König L, Welzel T, Debus J, Combs SE (2014) A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival. Radiat Oncol. doi:10.1186/1748-717X-9-95 Adeberg S, Bostel T, König L, Welzel T, Debus J, Combs SE (2014) A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival. Radiat Oncol. doi:10.​1186/​1748-717X-9-95
2.
Zurück zum Zitat Bohman LE, Swanson KR, Moore JL, Rockne R, Mandigo C, Hankinson T, Assanah M, Canoll P, Bruce JN (2010) Magnetic resonance imaging characteristics of glioblastoma multiforme: Implications for understanding glioma ontogeny. Neurosurg 67(5):1319–1327CrossRef Bohman LE, Swanson KR, Moore JL, Rockne R, Mandigo C, Hankinson T, Assanah M, Canoll P, Bruce JN (2010) Magnetic resonance imaging characteristics of glioblastoma multiforme: Implications for understanding glioma ontogeny. Neurosurg 67(5):1319–1327CrossRef
3.
Zurück zum Zitat Cage TA, Pekmezci M, Prados M, Berger MS (2013) Subependymal spread of recurrent glioblastoma detected with the intraoperative use of 5-aminolevulinic acid. J Neurosurg 118(6):1220–1223PubMedCrossRef Cage TA, Pekmezci M, Prados M, Berger MS (2013) Subependymal spread of recurrent glioblastoma detected with the intraoperative use of 5-aminolevulinic acid. J Neurosurg 118(6):1220–1223PubMedCrossRef
4.
Zurück zum Zitat Chaichana KL, McGirt MJ, Frazier J, Attenello F, Guerrero-Cazares H, Quinones-Hinojosa A (2008) Relationship of glioblastoma multiforme to the lateral ventricles predicts survival following tumor resection. J Neurooncol 89(2):219–224PubMedCrossRef Chaichana KL, McGirt MJ, Frazier J, Attenello F, Guerrero-Cazares H, Quinones-Hinojosa A (2008) Relationship of glioblastoma multiforme to the lateral ventricles predicts survival following tumor resection. J Neurooncol 89(2):219–224PubMedCrossRef
5.
Zurück zum Zitat Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Mischel PS, Pope WB (2011) Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab. Neuro Oncol 13(4):401–409PubMedCentralPubMedCrossRef Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Mischel PS, Pope WB (2011) Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab. Neuro Oncol 13(4):401–409PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Habberstad AH, Lind-Landström T, Sundstrøm S, Torp SH (2012) Primary human glioblastomas - prognostic value of clinical and histopathological parameters. Clin Neuropathol 31(5):361–368PubMedCrossRef Habberstad AH, Lind-Landström T, Sundstrøm S, Torp SH (2012) Primary human glioblastomas - prognostic value of clinical and histopathological parameters. Clin Neuropathol 31(5):361–368PubMedCrossRef
7.
Zurück zum Zitat Hayashi Y, Nakada M, Tanaka S, Uchiyama N, Hayashi Y, Kita D, Hamada J (2010) Implication of 5-aminolevulinic acid fluorescence of the ventricular wall for postoperative communicating hydrocephalus associated with cerebrospinal fluid dissemination in patients with glioblastoma multiforme: a report of 7 cases. J Neurosurg 112(5):1015–1019PubMedCrossRef Hayashi Y, Nakada M, Tanaka S, Uchiyama N, Hayashi Y, Kita D, Hamada J (2010) Implication of 5-aminolevulinic acid fluorescence of the ventricular wall for postoperative communicating hydrocephalus associated with cerebrospinal fluid dissemination in patients with glioblastoma multiforme: a report of 7 cases. J Neurosurg 112(5):1015–1019PubMedCrossRef
8.
Zurück zum Zitat Hoelscher M, Richter N, Melle C, von Eggeling F, Schaenzer A, Nestler U (2013) SELDI-TOF analysis of glioblastoma cyst fluid is an approach for assessing cellular protein expression. Neurol Res 35(10):993–1001PubMedCentralPubMedCrossRef Hoelscher M, Richter N, Melle C, von Eggeling F, Schaenzer A, Nestler U (2013) SELDI-TOF analysis of glioblastoma cyst fluid is an approach for assessing cellular protein expression. Neurol Res 35(10):993–1001PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Iliadis G, Kotoula V, Chatzisotiriou A, Televantou D, Eleftheraki AG, Lambaki S, Misailidou D, Selviaridis P, Fountzilas G (2012) Volumetric and MGMT parameters in glioblastoma patients: Survival analysis. MC Cancer. doi:10.1186/1471-2407-12-3 Iliadis G, Kotoula V, Chatzisotiriou A, Televantou D, Eleftheraki AG, Lambaki S, Misailidou D, Selviaridis P, Fountzilas G (2012) Volumetric and MGMT parameters in glioblastoma patients: Survival analysis. MC Cancer. doi:10.​1186/​1471-2407-12-3
10.
Zurück zum Zitat Kappadakunnel M, Eskin A, Dong J, Nelson SF, Mischel PS, Liau LM, Ngheimphu P, Lai A, Cloughesy TF, Goldin J, Pope WB (2010) Stem cell associated gene expression in glioblastoma multiforme: Relationship to survival and the subventricular zone. J Neurooncol 96(3):359–367PubMedCentralPubMedCrossRef Kappadakunnel M, Eskin A, Dong J, Nelson SF, Mischel PS, Liau LM, Ngheimphu P, Lai A, Cloughesy TF, Goldin J, Pope WB (2010) Stem cell associated gene expression in glioblastoma multiforme: Relationship to survival and the subventricular zone. J Neurooncol 96(3):359–367PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Kimura M, Lee Y, Miller R, Castillo M (2013) Glioblastoma multiforme: Relationship to subventricular zone and recurrence. Neuroradiol J 26(5):542–547PubMed Kimura M, Lee Y, Miller R, Castillo M (2013) Glioblastoma multiforme: Relationship to subventricular zone and recurrence. Neuroradiol J 26(5):542–547PubMed
12.
Zurück zum Zitat Lim DA, Cha S, Mayo MC, Chen MH, Keles E, van den Berg S, Berger MS (2007) Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro Oncol 9(4):424–429PubMedCentralPubMedCrossRef Lim DA, Cha S, Mayo MC, Chen MH, Keles E, van den Berg S, Berger MS (2007) Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro Oncol 9(4):424–429PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Naeini KM, Pope WB, Cloughesy TF, Harris RJ, Lai A, Eskin A, Chowdhury R, Phillips HS, Nghiemphu PL, Behbahanian Y, Ellingson BM (2013) Identifying the mesenchymal molecular subtype of glioblastoma using quantitative volumetric analysis of anatomic magnetic resonance images. Neuro Oncol 15(5):626–634PubMedCentralPubMedCrossRef Naeini KM, Pope WB, Cloughesy TF, Harris RJ, Lai A, Eskin A, Chowdhury R, Phillips HS, Nghiemphu PL, Behbahanian Y, Ellingson BM (2013) Identifying the mesenchymal molecular subtype of glioblastoma using quantitative volumetric analysis of anatomic magnetic resonance images. Neuro Oncol 15(5):626–634PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Recht L, Jang T, Savarese T, Litofsky NS (2003) Neural stem cells and neuro-oncology: Quo vadis. J Cell Biochem 88:11–19PubMedCrossRef Recht L, Jang T, Savarese T, Litofsky NS (2003) Neural stem cells and neuro-oncology: Quo vadis. J Cell Biochem 88:11–19PubMedCrossRef
15.
Zurück zum Zitat Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ; ALA-Glioma Study Group (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7(5):392–401 Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ; ALA-Glioma Study Group (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7(5):392–401
16.
17.
Zurück zum Zitat Tejada-Solís S, Aldave-Orzaiz G, Pay-Valverde E, Marigil-Sánchez M, Idoate- Gastearena MA, Díez-Valle R (2012) Prognostic value of ventricular wall fluorescence during 5-aminolevulinic-guided surgery for glioblastoma. Acta Neurochir 154(11):1997–2002PubMedCrossRef Tejada-Solís S, Aldave-Orzaiz G, Pay-Valverde E, Marigil-Sánchez M, Idoate- Gastearena MA, Díez-Valle R (2012) Prognostic value of ventricular wall fluorescence during 5-aminolevulinic-guided surgery for glioblastoma. Acta Neurochir 154(11):1997–2002PubMedCrossRef
Metadaten
Titel
Anatomic features of glioblastoma and their potential impact on survival
verfasst von
U. Nestler
K. Lutz
U. Pichlmeier
W. Stummer
K. Franz
H-J Reulen
A. Bink
on behalf of the 5-ALA Glioma Study Group
Publikationsdatum
01.02.2015
Verlag
Springer Vienna
Erschienen in
Acta Neurochirurgica / Ausgabe 2/2015
Print ISSN: 0001-6268
Elektronische ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-014-2271-x

Weitere Artikel der Ausgabe 2/2015

Acta Neurochirurgica 2/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.